BlackRock Science and Technology Trust Stock News

The proverbial shot-across-the-bow came last week as the markets finally reacted to inflation fears as reflected in the sizzling CPI (Consumer Price Index) and PPI (Producer Price Index) numbers.

NEW YORK--(BUSINESS WIRE)--BlackRock today announced the release of the first quarter fund commentary for BlackRock Science and Technology Trust II (NYSE: BSTZ, CUSIP: 09260K101 or the “Trust”). B

Don't Buy QYLD: Buy These CEFs Instead

Added to two positions in March and started a new position in one fund.

As a shift to value from growth stocks is occurring, it can be creating longer-term buy opportunities.

Looking at addressing a question that comes up frequently about if a closed-end fund is right for you. Just because you have a high income portfolio, doesn't mean you can't achieve growth too through

Equity CEFs: The NAV Doesn't Lie And Why You Should Be Selling The Cornerstone Funds

BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private i

BSTZ was the top-performing closed-end fund in 2020. Chances are 2021 might not be so spectacular, but that doesn't mean strong returns can't be achieved again. As we entered into 2021, pressure mount

For the second month in a row, equity CEFs on average posted positive returns, rising 3.78% on a NAV basis for December. While for the ninth month running, fixed income CEFs witnessed returns in the b

Some readers had showed interest in hearing what my personal top ten positions are. Using Portfolio Visualizer's tools looking through my top ten can provide some interesting data.

It's one of the most time-tested theories in the markets.  That the market is efficient and will price in all the knowable facts of any security at any given moment. That may work for stocks and thei

BSTZ has been on fire, as it is invested in all the hot tech plays. The fund is paying out attractive monthly income, and shareholders just got a big boost in the amount too.

BSTZ has outperformed the market in 2020 - it's up 28%, but still has a 7.75% discount to NAV. It holds 43% in mid- and small-cap science and tech stocks.

BMEZ is a fund that is focused on the healthcare space, more specifically, a focus on the health sciences industry.